Notably, this migratory defect was linked to the route of vaccine administration: intranasal vaccination, but not intramuscular, induced significantly higher and more sustained levels of CXCL16 in bronchoalveolar lavage fluid and lung parenchyma, thereby promoting optimal TRM positioning and tumor control in pulmonary tissues [66]. This evidence concerns the gene CXCL16 and neoplasm.